Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Shipped fast
In Long-Acting GLP-1/Glucagon Dual Agonist SP-1373 Shows Superior Body and Liver Weight Loss in DIO Rodent Models Relevant to Diabetes and NASH (Spitfire Pharma, Inc., 77th American Diabetes Association Scientific Sessions, 2017)
Newer oral GLP-1 options like the Wegovy pill are more affordable currently around $149 per month but clinical trials show they deliver somewhat less weight loss than injectables, averaging around 1516% compared to 20% or more with injections. For patients who need significant weight loss to resolve health conditions, a lower-cost medication that produces fewer results may not be enough
1b, left panel)
Distributing one injection point every 1.0 cm ensures the entire treatment area is completely wrapped in high-concentration natural enzymes within 20 minutes
